Marketing-authorisation holder
Nt Pharma Canada Ltd
34 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 34
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| NTP-METFORMIN850 mg · Tablet | Metformin | Canada | Cancelled | |
| NTP-METFORMIN500 mg · Tablet | Metformin | Canada | Cancelled | |
| NTP-METHYLPHENIDATE ER-C36 mg · Tablet (Extended-Release) | Methylphenidate | Canada | Cancelled | |
| NTP-METHYLPHENIDATE ER-C27 mg · Tablet (Extended-Release) | Methylphenidate | Canada | Cancelled | |
| NTP-METHYLPHENIDATE ER-C18 mg · Tablet (Extended-Release) | Methylphenidate | Canada | Cancelled | |
| NTP-METHYLPHENIDATE ER-C54 mg · Tablet (Extended-Release) | Methylphenidate | Canada | Cancelled | |
| NTP-OXYCODONE ACETAMINOPHEN325 mg + 5 mg · Tablet | Paracetamol, Oxycodone | Canada | Cancelled | |
| NTP-PANTOPRAZOLE40 mg · Tablet (Delayed-Release) | Pantoprazole | Canada | Cancelled | |
| NTP-PANTOPRAZOLE20 mg · Tablet (Delayed-Release) | Pantoprazole | Canada | Cancelled | |
| NTP-PRAMIPEXOLE1.0 mg · Tablet | Pramipexole | Canada | Cancelled | |
| NTP-PRAMIPEXOLE0.25 mg · Tablet | Pramipexole | Canada | Cancelled | |
| NTP-PRAMIPEXOLE0.5 mg · Tablet | Pramipexole | Canada | Cancelled | |
| NTP-PRAMIPEXOLE1.5 mg · Tablet | Pramipexole | Canada | Cancelled | |
| NTP-RABEPRAZOLE EC10 mg · Tablet (Delayed-Release) | Rabeprazole | Canada | Cancelled | |
| NTP-RABEPRAZOLE EC20 mg · Tablet (Delayed-Release) | Rabeprazole | Canada | Cancelled | |
| NTP-RAMIPRIL5 mg · Capsule | Ramipril | Canada | Cancelled | |
| NTP-RAMIPRIL10 mg · Capsule | Ramipril | Canada | Cancelled | |
| NTP-RAMIPRIL2.5 mg · Capsule | Ramipril | Canada | Cancelled | |
| NTP-RISEDRONATE35 mg · Tablet | Risedronate | Canada | Cancelled | |
| NTP-RISEDRONATE30 mg · Tablet | Risedronate | Canada | Cancelled | |
| NTP-RISEDRONATE5 mg · Tablet | Risedronate | Canada | Cancelled | |
| NTP-SIMVASTATIN80 mg · Tablet | Simvastatin | Canada | Cancelled | |
| NTP-SIMVASTATIN40 mg · Tablet | Simvastatin | Canada | Cancelled | |
| NTP-SIMVASTATIN5 mg · Tablet | Simvastatin | Canada | Cancelled | |
| NTP-SIMVASTATIN10 mg · Tablet | Simvastatin | Canada | Cancelled |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 34 | 0 | 34 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Lipid-modifying agentsCardiovascular system · ATC C10A
- Drugs for acid-related disordersAlimentary tract and metabolism · ATC A02B
- Anti-Parkinson drugsNervous system · ATC N04B
- PsychoanalepticsNervous system · ATC N06B
- Agents acting on the renin–angiotensin systemCardiovascular system · ATC C09A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- nt pharma canada
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 34
- Countries
- 1
- Roles
- Authorisation holder